Genzyme biopharmaceuticals news

GENZ opened U.K. R&D facilities in Cambridge and Haverhill. The company also opened a biomanufacturing plant in Geel, Belgium, to produce monoclonal antibodies, proteins and Myozyme alglucosidase alf...